VERIFIED AUTHENTIC
Batch verification — Retatrutide
PV-43BE4D-JUHD-B1
This batch has been independently analysed and verified by an ISO/IEC 17025-aligned laboratory. Identity confirmed by mass spectrometry; chromatographic purity confirmed at single-peak resolution.
99.69%
VERIFIED PURITY · HPLC, SINGLE PEAK
IDENTITY
PEPTIDERetatrutide
FORMATLyophilised single peptide
CUSTOMERThePeptideCode
BATCH NUMBERBTFW003
VERIFICATION IDPV-43BE4D-JUHD-B1
MS VERIFICATION✓ Confirmed
MASS SPECTROMETRY
EXPECTED MW4731.4 Da
DETECTED MW4730.4 Da
MASS ACCURACY±1.0 Da, within tolerance
METHODHPLC + LC-MS
INSTRUMENTLCMS
CHROMATOGRAPHY
TOTAL PEAKS1 (single peak)
MAIN PEAK RT9.867 min
PURITY (HPLC)99.69%
DATES
ANALYSIS DATE05 May 2026
CERTIFICATE DATE07 May 2026
What this verifies
- Identity confirmed — observed monoisotopic mass within ±1.0 Da of the theoretical 4731.4 Da
- Single-peak resolution at RP-HPLC, 214 nm — no related impurities detected above method LOQ
- 99.69% chromatographic purity exceeds the ≥ 99% release specification
- Result issued by an ISO/IEC 17025-aligned independent laboratory
- Tamper-evident vial sealing under ICH Q7 / WHO GMP-aligned manufacturing
How to read this report
This page summarises the analytical release data for this batch. The complete certificate — including the integrated HPLC chromatogram, the annotated ESI-MS mass spectrum, lab signature, and accreditation reference — is available via the PeptideVerify link above. Each retained sample is sealed and logged against this verification ID. The same ID appears on your vial label and packing slip.
Related pages
Product: Retatrutide 30mg · Verification & Testing
Other verified batches: KLOW80 · CJC-1295 + Ipamorelin · GHK-Cu · Tirzepatide